首都医学科学创新中心-Challenges and opportunities in research of autoimmune diseases

当前位置：首页 > 科学研究 > 学术报告 > 医学创新论坛 > 正文

Challenges and opportunities in research of autoimmune diseases

发布时间：2025-03-12

医学创新论坛第61期

CIMR Wednesday Lecture Series

时间：2025年3月12日（周三）下午16:00

地点：首都医科大学基础科研楼北楼一层逸夫报告厅

主持人：

李川源

首都医学科学创新中心

报告人：

栗占国

北京大学人民医院风湿免疫科/风湿免疫研究所

报告题目：

Challenges and opportunities in research of autoimmune diseases

摘要：

Autoimmune diseases are a heterogeneous group of disorder including systemic lupus erythematosus, rheumatoid arthritis and ankylosing spondylitis, affecting 10.1% of the population worldwide. Clinical features of these diseases are systemic organ impairments, vasculitis and destructive arthritis, associated with immune abnormality and autoantibody production. There are unmet needs in early diagnosis and rational treatment, leading to disability, and increased mortality. Recent improvement has been achieved in better understanding of molecular mechanism and development of promising therapies for these diseases. However, specific biomarkers and targeting treatments are expected clinically to improve the prognosis of these autoimmune conditions, especially in long term remission and immune homeostasis. The lecture will focus on the challenges and opportunities in research of these autoimmune diseases.

代表性论文：

1. Li C, Huang J, Wu H, Li F, Zhao Y, Zhang Z, Li S, Wei H, Zhang M, Sun H, Yang J, Li Q, Li X, Qi W, Wei W, Li Y, Li Z, Wang Y, Zhang F, Wu H, Shuai Z, Wu Z, Li Y, Jia S, Jia Y, Xiao F, Mu R, Li Z. Management of Rheumatoid Arthritis With a Digital Health Application: A Multicenter, Pragmatic Randomized Clinical Trial. JAMA Netw Open. 2023 Apr 3;6(4):e238343.

2. He J, Chu Y, Li J, Meng Q, Liu Y, Jin J, Wang Y, Wang J, Huang B, Shi L, Shi X, Tian J, Zhufeng Y, Feng R, Xiao W, Gan Y, Guo J, Shao C, Su Y, Hu F, Sun X, Yu J, Kang Y, Li Z. Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis. Sci Adv. 2022 Feb 11;8(6):eabm1511.

3. He J, Chen J, Miao M, Zhang R, Cheng G, Wang Y, Feng R, Huang B, Luan H, Jia Y, Jin Y, Zhang X, Shao M, Wang Y, Zhang X, Li J, Zhao X, Wang H, Liu T, Xiao X, Zhang X, Su Y, Mu R, Ye H, Li R, Liu X, Liu Y, Li C, Liu H, Hu F, Guo J, Liu W, Zhang WB, Jacob A, Ambrus JL Jr, Ding C, Yu D, Sun X, Li Z. Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2022 Nov 1;5(11):e2241451.